Fernando Martinez Estrada
Honorary Departmental Senior Research Associate
I am a Senior research Associate in Macrophage pathobiology. I am originally from Havana-Cuba, where I graduated as Biochemist to then pursue a doctorate in Molecular Medicine and Immunology in Milan-Italy; I then joined Oxford University.
My main objectives in science are to understand how macrophages participate in disease pathogenesis and to identify new avenues to interfere with their deleterious properties. Macrophages are present in all tissues, numerous, and their role in inflammation is primarily controlled by modulation of their gene and protein repertoire. The transcriptome of macrophages holds the key to the fundamental question in macrophage pathobiology and inflammatory medicine: how to inactivate and reprogramme the macrophage.
My areas of expertise are macrophage cellular and systems biology (isolation-culture, gene and proteomic signatures, microarrays, proteomics, functional analysis), regulation of macrophage activation, and modern pathology. I use techniques to complement my transcriptome work, including conventional histological techniques, and modern developments such as multiple immunofluorescence histology, multiple FACS staining and Cytof. The application of the knowledge that I derive with my tools, allows re interpretation of conventional paradigms and proposals of new ways of understanding disease and potential treatments.
Key publications
-
The M1 and M2 paradigm of macrophage activation: time for reassessment.
Journal article
Martinez FO. and Gordon S., (2014), F1000prime rep, 6
-
Alternative activation of macrophages: mechanism and functions.
Journal article
Gordon S. and Martinez FO., (2010), Immunity, 32, 593 - 604
-
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences.
Journal article
Martinez FO. et al, (2013), Blood, 121, e57 - e69
-
Macrophage activation and polarization: nomenclature and experimental guidelines.
Journal article
Murray PJ. et al, (2014), Immunity, 41, 14 - 20
Recent publications
-
Diminished placental Factor XIIIA1 expression associates with pre-conception antiretroviral treatment and preterm birth in pregnant people living with HIV.
Journal article
Ojwach D. et al, (2024), Biorxiv
-
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.
Journal article
Tapmeier TT. et al, (2021), Sci transl med, 13
-
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.
Journal article
Tapmeier TT. et al, (2021), Sci transl med, 13
-
Pathogen-induced inflammation is attenuated by the iminosugar MON-DNJ via modulation of the unfolded protein response.
Journal article
Sayce AC. et al, (2021), Immunology
-
CSF1R defines the mononuclear phagocyte system lineage in human blood in health and COVID-19.
Journal article
Combes TW. et al, (2021), Immunother adv, 1